Metastatic gastric cancer is an incurable disease. Systemic chemotherapy prolongs survival, improves symptom control, and helps maintain a better quality of life of patients with metastatic gastric cancer. HER2 testing of the primary tumor and/or the metastases is warranted before initiation of first-line treatment. This review article outlines the indication and clinical data of medical treatment of advanced gastric cancer and highlights aspects of quality of life.
Keywords: Chemotherapy; Doublet; Gastric cancer; Metastases; Radiotherapy; Sequence; Surgery; Triplet.
Copyright © 2017 Elsevier Inc. All rights reserved.